We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Membrane Blue Versus Infracyanine Green

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00555269
Recruitment Status : Completed
First Posted : November 8, 2007
Last Update Posted : April 22, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
To compare possible toxicities of membrane blue and infracyanine green in vivo by macular function and peripheral visual field.

Condition or disease
Macular Pucker Macular Hole

Study Design

Study Type : Observational
Actual Enrollment : 30 participants
Time Perspective: Prospective
Official Title: Comparison of Macular Function and Visual Fields After Membrane Blue or Infracyanine Green Staining in Vitreoretinal Surgery
Study Start Date : October 2004
Study Completion Date : December 2005
Groups and Cohorts

Group/Cohort
MB
IFCG


Outcome Measures

Primary Outcome Measures :
  1. Visual acuity, macular thickness and peripheral visual field

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Study Population
Patients with a macular pucker or a macular hole, without any other retinal disease
Criteria

Inclusion Criteria:

  • Macular pucker or macular hole

Exclusion Criteria:

  • Any other retinal disease
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00555269


Sponsors and Collaborators
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Investigators
Principal Investigator: Katharina E Schmid-Kubista, MD Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Univ.Prof.Dr. Susanne Binder, Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
ClinicalTrials.gov Identifier: NCT00555269     History of Changes
Other Study ID Numbers: MB vs IFCG
First Posted: November 8, 2007    Key Record Dates
Last Update Posted: April 22, 2009
Last Verified: April 2009

Keywords provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:
Macular pucker
Macular hole
Membrane Blue
Infracyanine Green
Peripheral Visual Field

Additional relevant MeSH terms:
Retinal Perforations
Epiretinal Membrane
Retinal Diseases
Eye Diseases